Á lódáil...
Hepatic Decompensation Likely Attributable to Simeprevir in Patients with Advanced Cirrhosis
BACKGROUND: Hyperbilirubinemia is a common side effect of protease inhibitors used to treat chronic hepatitis C (HCV), and most patients do not experience without clinically overt hepatotoxicity. The safety of second-wave protease inhibitors, including simeprevir, has not been well studied in patien...
Na minha lista:
| Foilsithe in: | Dig Dis Sci |
|---|---|
| Main Authors: | , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
2014
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6600814/ https://ncbi.nlm.nih.gov/pubmed/25373453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10620-014-3422-x |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|